Effect of Vaccination Against E. coli, C. perfringens Type A/C on Piglet Productive and Clinical Parameters Under Field Conditions

cris.virtual.author-orcid0000-0003-0270-2914
cris.virtual.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.author-orcid0000-0002-1610-0589
cris.virtual.author-orcid0000-0002-4509-8852
cris.virtual.author-orcid0000-0001-9874-6895
cris.virtual.author-orcid0000-0003-2220-2730
cris.virtualsource.author-orcidabb21f0b-d43c-470d-99e6-7b59a4439244
cris.virtualsource.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtualsource.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtualsource.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtualsource.author-orcidcfb82b96-7ef9-4b03-b4fb-1a3075fd805e
cris.virtualsource.author-orcid702c3b7e-b378-411f-bc9b-510fe73f43da
cris.virtualsource.author-orcid6fc589c0-a9dd-4835-bb57-7f31154633df
cris.virtualsource.author-orcid71dccebf-e765-40b9-87bb-e98ab3b7299c
dc.abstract.enBackground: One of the main strategies to control neonatal porcine diarrhoea (NPD) is through vaccination of the sows. This study aimed to compare the efficacy of two commercial vaccination schemes under field conditions on a farm where a C. perfringens type A cpb2-positive strain was implicated in NPD. Methods: This study was performed in a farrow-to-wean herd with 5500 sows, already using an E. coli and C. perfringens vaccine but still suffering NPD. Where the presence of a C. perfringens type A cpb2-positive strain was confirmed, Enteroporc Coli AC® (Ceva) was administrated to the sows in group A according to the manufacturer’s instructions. Sows in group B were vaccinated using two other combined commercial vaccines. In each group, piglets from 10 litters were ear-tagged and individually weighed at birth and at 8 and 22 days of age. The incidence of diarrhoea, general piglet body condition, and antimicrobial treatment were recorded within 10 consecutive days after birth. Results: A total of 234 piglets (119 in group A and 115 in group B) were included. The mean weight gain of piglets from birth to 22 days of age was significantly higher in group A (4.99 kg) than in group B (4.66 kg) (p = 0.039). The rest of the recorded parameters such as the presence of diarrhoea, the piglet’s body condition score, and the number of days with antimicrobial treatment did not differ significantly between groups. Conclusions: This study confirmed the efficiency of the Enteroporc Coli AC® vaccine in reducing clinical symptoms of diarrhoea in piglets, which was comparable with the other vaccines used in the study. The positive effect on piglets’ productive performance during the lactation phase was observed.
dc.affiliationWydział Medycyny Weterynaryjnej i Nauk o Zwierzętach
dc.affiliation.instituteKatedra Nauk Przedklinicznych i Chorób Zakaźnych
dc.contributor.authorDors, Arkadiusz
dc.contributor.authorPanek, Robert
dc.contributor.authorŁużyński, Wojciech
dc.contributor.authorJaneczko, Krzysztof
dc.contributor.authorAugustyniak, Agata
dc.contributor.authorTurlewicz-Podbielska, Hanna
dc.contributor.authorCzyżewska-Dors, Ewelina
dc.contributor.authorPomorska-Mól, Małgorzata
dc.date.access2025-01-07
dc.date.accessioned2025-01-07T10:10:25Z
dc.date.available2025-01-07T10:10:25Z
dc.date.copyright2024-10-17
dc.date.issued2024
dc.description.abstract<jats:p>Background: One of the main strategies to control neonatal porcine diarrhoea (NPD) is through vaccination of the sows. This study aimed to compare the efficacy of two commercial vaccination schemes under field conditions on a farm where a C. perfringens type A cpb2-positive strain was implicated in NPD. Methods: This study was performed in a farrow-to-wean herd with 5500 sows, already using an E. coli and C. perfringens vaccine but still suffering NPD. Where the presence of a C. perfringens type A cpb2-positive strain was confirmed, Enteroporc Coli AC® (Ceva) was administrated to the sows in group A according to the manufacturer’s instructions. Sows in group B were vaccinated using two other combined commercial vaccines. In each group, piglets from 10 litters were ear-tagged and individually weighed at birth and at 8 and 22 days of age. The incidence of diarrhoea, general piglet body condition, and antimicrobial treatment were recorded within 10 consecutive days after birth. Results: A total of 234 piglets (119 in group A and 115 in group B) were included. The mean weight gain of piglets from birth to 22 days of age was significantly higher in group A (4.99 kg) than in group B (4.66 kg) (p = 0.039). The rest of the recorded parameters such as the presence of diarrhoea, the piglet’s body condition score, and the number of days with antimicrobial treatment did not differ significantly between groups. Conclusions: This study confirmed the efficiency of the Enteroporc Coli AC® vaccine in reducing clinical symptoms of diarrhoea in piglets, which was comparable with the other vaccines used in the study. The positive effect on piglets’ productive performance during the lactation phase was observed.</jats:p>
dc.description.accesstimeat_publication
dc.description.bibliographyil., bibliogr.
dc.description.financepublication_research
dc.description.financecost12271,99
dc.description.if5,2
dc.description.number10
dc.description.points140
dc.description.reviewreview
dc.description.versionfinal_published
dc.description.volume12
dc.identifier.doi10.3390/vaccines12101185
dc.identifier.issn2076-393X
dc.identifier.urihttps://sciencerep.up.poznan.pl/handle/item/2275
dc.identifier.weblinkhttps://www.mdpi.com/2076-393X/12/10/1185
dc.languageen
dc.pbn.affiliationveterinary science
dc.relation.ispartofVaccines
dc.relation.pagesart. 1185
dc.rightsCC-BY
dc.sciencecloudsend
dc.share.typeOPEN_JOURNAL
dc.subject.enneonatal diarrhoea
dc.subject.enClostridium perfringens
dc.subject.enalpha toxin
dc.subject.enbeta2 toxin
dc.subject.envaccination
dc.subject.enpiglets
dc.titleEffect of Vaccination Against E. coli, C. perfringens Type A/C on Piglet Productive and Clinical Parameters Under Field Conditions
dc.title.volumeSpecial Issue: Porcine Vaccines: Enhancing Health, Productivity, and Welfare
dc.typeJournalArticle
dspace.entity.typePublication
oaire.citation.issue10
oaire.citation.volume12
project.funder.namePREIDUB